Predictors of 1-year survival assessed at the time of bone marrow transplantation

Grace Chang1, E John Orav, Mei-Yee Tong

  • 1Brigham and Women's Hospital, Boston, MA, USA. Gchang@partners.org

Psychosomatics
|September 4, 2004
PubMed

Insights

Predictors of survival after allogeneic hematopoietic stem cell transplantation (HSCT) for chronic myelogenous leukemia were examined. Pre-transplant psychosocial factors did not impact 1-year survival, but clinical variables did.

Area of Science:

  • Hematology
  • Oncology
  • Transplantation Medicine

Background:

  • Allogeneic hematopoietic stem cell transplantation (HSCT) is a critical treatment for chronic myelogenous leukemia (CML).
  • Identifying factors that predict survival post-HSCT is crucial for improving patient outcomes.
  • Previous research has explored various predictors, but the role of psychosocial factors requires further investigation.

Purpose of the Study:

  • To identify pretransplant and transplant-related predictors of 1-year survival in patients undergoing allogeneic HSCT for CML.
  • To assess the impact of psychosocial and behavioral variables on HSCT outcomes.

Main Methods:

  • Prospective cohort study involving 114 patients with CML undergoing allogeneic HSCT.
  • Systematic assessment of psychosocial and behavioral variables (alcohol abuse, smoking, depression, quality of life) using structured instruments.
  • Analysis of pretransplant and transplant clinical variables as potential predictors of 1-year survival.

Main Results:

  • The overall 1-year survival rate was 66%.
  • Pre-transplant lifetime alcohol and substance use, cigarette smoking, depression, and quality of life were not found to significantly affect 1-year survival.
  • Certain pre-transplant and transplant-related clinical variables were identified as significant predictors of survival.

Conclusions:

  • Psychosocial and behavioral factors assessed did not emerge as significant predictors of 1-year survival after allogeneic HSCT for CML.
  • Clinical variables remain critical predictors of survival in this patient population.
  • Further research should focus on elucidating the specific clinical factors influencing HSCT outcomes in CML.